Loss of cannabinoid receptor 2 promotes α-Synuclein-induced microglial synaptic pruning in nucleus accumbens by

Linjuan Feng1, Hsuan Lo2, Hanlin You1

  • 1Department of Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, China; Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, China; Institute of Clinical Neurology, Fujian Medical University, 29 Xinquan Road, Fuzhou 350001, China; Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, 88 Jiaotong Road, Fuzhou 350001, China.

Experimental Neurology
|September 26, 2022
PubMed

Insights

Cannabinoid receptor 2 (CB2R) deletion in microglia exacerbates alpha-synucleinopathy in the nucleus accumbens by promoting synaptic pruning. CB2R deficiency disrupts microglial function, impacting mood and learning behaviors.

Area of Science:

  • Neuroscience
  • Neuroimmunology
  • Synaptic Plasticity

Background:

  • Alpha-synucleinopathy disrupts nucleus accumbens (NAc) function, affecting mood and learning.
  • Microglial synaptic pruning is a key factor in neuropathological progression.
  • Cannabinoid receptor 2 (CB2R) activation in microglia reduces inflammation, but its role in synaptic pruning during alpha-synucleinopathy is unclear.

Purpose of the Study:

  • To investigate the role of CB2R in microglia-mediated synaptic pruning within the NAc during alpha-synucleinopathy.
  • To characterize the effects of genetic CB2R deletion on microglial function and associated signaling pathways.

Main Methods:

  • Utilized fibrillar alpha-synuclein (α-Syn) treatment in CB2R knockout (CB2-/-) and wild-type (CB2+/+) mice.
  • Employed immunofluorescence, real-time PCR, and western blotting to assess synaptic pruning and microglial activation.
  • Investigated underlying mechanisms of CB2R in α-Syn-induced microglial activity in vitro.

Main Results:

  • CB2R deletion led to distinct microglial morphological changes and M1 phenotype transformation post-α-Syn treatment.
  • CB2-/- mice exhibited increased CD68 and IL-1β, with decreased BDNF and TGF-β mRNA compared to CB2+/+ mice.
  • CB2-/- microglia showed enhanced complement 3a receptor (C3aR) expression, leading to excessive cholinergic synapse pruning and reduced dopaminergic synapse engulfment.
  • Loss of CB2R function triggered c-Fos activation and pCREB-c-Fos signaling, linked to C3aR upregulation.

Conclusions:

  • CB2R plays a critical mechanistic role in modulating microglial function and synaptic circuit homeostasis in the NAc during α-synucleinopathy.
  • Targeting CB2R may offer therapeutic potential for managing synaptic dysfunction in α-synucleinopathies.